Trial
NCT01118975
GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
University of Maryland Greenebaum Cancer Center
Condition
Breast Cancer
Intervention
Vorinostat
Why stopped
Lost sponsorship for study drug
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-13